过去一年中添加的文章，按日期排序
… in Treatment of Premenstrual Syndrome with Gan (Liver) Depression and Qi Stagnation Syndrome: A Randomized, Double-Blind, Multi-Center, Phase-II Clinical Trial
X Teng, L Xu, J Lin, J Zhang, Q Zhang, Y Sun… - Chinese Journal of …, 2024 - Springer
5 天前 - … (CM) syndrome efficacy. PMSD, PMTS, and efficacy of CM were evaluated with
menstrual … High-dose GYSG might be the optimal dose for a phase III trial. (Registration No. …
menstrual … High-dose GYSG might be the optimal dose for a phase III trial. (Registration No. …
… for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: A multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial
W Zuo, Z Wang, J Qian, X Ma, Z Niu, J Ou, Q Mo… - British Journal of …, 2024 - nature.com
6 天前 - … this randomized, multicenter, double-blinded phase III trial … early-stage or locally
advanced breast cancer. The … In this study, the primary efficacy assessment focused on …
advanced breast cancer. The … In this study, the primary efficacy assessment focused on …
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients With …
FA Bethoux, R Farrell, D Checketts, N Sahr… - Multiple Sclerosis and …, 2024 - Elsevier
7 天前 - … The primary efficacy measure used in this study, the MAS LLMT-6, was initially
defined on the basis of a post hoc analysis of data from completed studies, [Nicholas et al., 2023] …
defined on the basis of a post hoc analysis of data from completed studies, [Nicholas et al., 2023] …
Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study
S Parke, K Gude, K Roth, F Messina - BMC Women's Health, 2024 - Springer
8 天前 - … The phase 2b SCHUMANN study aimed to identify the optimal dose of eliapixant in
patients with EAPP, to further assess efficacy… an optimum dose for further phase 3 trials [34]. …
patients with EAPP, to further assess efficacy… an optimum dose for further phase 3 trials [34]. …
Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled …
KI Han, TH Kim, SW Ra, HK Yoon, DK Kim… - Current Medical …, 2024 - Taylor & Francis
8 天前 - … We performed a multicenter, randomized, double-blind, active-controlled, parallel
phase III study in 220 patients with acute bronchitis. The participants were offered either …
phase III study in 220 patients with acute bronchitis. The participants were offered either …
… after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
YK Kang, M Terashima, YW Kim, N Boku… - The Lancet …, 2024 - thelancet.com
9 天前 - … stage III gastric or gastro-oesophageal junction (GEJ) cancer. We aimed to
assess the efficacy and safety of adjuvant nivolumab plus chemotherapy versus placebo plus …
assess the efficacy and safety of adjuvant nivolumab plus chemotherapy versus placebo plus …
Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial
M Mittelman, DH Henry, JA Glaspy… - American Journal of …, 2024 - Wiley Online Library
9 天前 - … randomized, doubleblind, phase 3 trial evaluated roxadustat versus placebo for
patients … the first prospective, randomized controlled trial to evaluate the efficacy and safety of …
patients … the first prospective, randomized controlled trial to evaluate the efficacy and safety of …
A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A …
SY Choi, YG Koh, YW Lee, HS Son… - Journal of …, 2024 - Taylor & Francis
10 天前 - … This clinical trial is a phase 3 study designed to evaluate the efficacy and safety of
BMI2006, a newly developed BoNT-A formulation. It aims to compare the effectiveness and …
BMI2006, a newly developed BoNT-A formulation. It aims to compare the effectiveness and …
… of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study
S Qin, Y Wang, J Yao, Y Liu, T Yi… - Therapeutic …, 2024 - journals.sagepub.com
12 天前 - … This study aimed to evaluate the efficacy and safety of hetrombopag for the …
However, a phase III study of avatrombopag, while confirming increased platelet counts in treated …
However, a phase III study of avatrombopag, while confirming increased platelet counts in treated …
[HTML][HTML] Incb28060 Inhibitor
M Kudo, AL Cheng, JW Park, JH Park, PC Liang… - incb28060inhibitor.com
13 天前 - … Therefore, we did a randomised, double-blind, placebo-controlled phase 3 trial
to evaluate the efficacy of orantinib combined with cTACE in patients with advanced …
to evaluate the efficacy of orantinib combined with cTACE in patients with advanced …